Disputes over mRNA-related patents are poised to persist.
Lynn Russo, JD, PhD
Advertisement
Articles by Lynn Russo, JD, PhD
Advertisement
Latest Updated Articles
IP and COVID-19Published: March 11th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
Bob Mauch: Strengthening the Chain
3
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
4
mRNA Covid Vaccines Display Potential to Benefit Immunotherapy Cancer Drugs
5
